Gilead’s Antiviral Remdesivir Had A Good Day - But It’s Still Not Clear How Effective It Is Against COVID-19

Results from two different studies released Wednesday about the use of Gilead Sciences’ GILD antiviral treatment remdesivir provide further evidence that it may be effective as a treatment for severe cases of COVID-19, though a smaller study published the same day suggests it may be no more effective than a placebo.